Literature DB >> 21703262

Insulin resistance impairs nigrostriatal dopamine function.

J K Morris1, G L Bomhoff, B K Gorres, V A Davis, J Kim, P-P Lee, W M Brooks, G A Gerhardt, P C Geiger, J A Stanford.   

Abstract

Clinical studies have indicated a link between Parkinson's disease (PD) and Type 2 Diabetes. Although preclinical studies have examined the effect of high-fat feeding on dopamine function in brain reward pathways, the effect of diet on neurotransmission in the nigrostriatal pathway, which is affected in PD and parkinsonism, is less clear. We hypothesized that a high-fat diet, which models early-stage Type 2 Diabetes, would disrupt nigrostriatal dopamine function in young adult Fischer 344 rats. Rats were fed a high fat diet (60% calories from fat) or a normal chow diet for 12 weeks. High fat-fed animals were insulin resistant compared to chow-fed controls. Potassium-evoked dopamine release and dopamine clearance were measured in the striatum using in vivo electrochemistry. Dopamine release was attenuated and dopamine clearance was diminished in the high-fat diet group compared to chow-fed rats. Magnetic resonance imaging indicated increased iron deposition in the substantia nigra of the high fat group. This finding was supported by alterations in the expression of several proteins involved in iron metabolism in the substantia nigra in this group compared to chow-fed animals. The diet-induced systemic and basal ganglia-specific changes may play a role in the observed impairment of nigrostriatal dopamine function.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703262      PMCID: PMC3169014          DOI: 10.1016/j.expneurol.2011.06.005

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  75 in total

1.  Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

Authors:  J M Graham; M N Paley; R A Grünewald; N Hoggard; P D Griffiths
Journal:  Brain       Date:  2000-12       Impact factor: 13.501

Review 2.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

3.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

4.  Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat.

Authors:  Jon F Davis; Andrea L Tracy; Jennifer D Schurdak; Matthias H Tschöp; Jack W Lipton; Deborah J Clegg; Stephen C Benoit
Journal:  Behav Neurosci       Date:  2008-12       Impact factor: 1.912

Review 5.  The source of cerebral insulin.

Authors:  William A Banks
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

6.  High-fat diet exposure increases dopamine D2 receptor and decreases dopamine transporter receptor binding density in the nucleus accumbens and caudate putamen of mice.

Authors:  Timothy South; Xu-Feng Huang
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

7.  The effect of vascular disease on late onset Parkinson's disease.

Authors:  S Papapetropoulos; J Ellul; A A Argyriou; P Talelli; E Chroni; T Papapetropoulos
Journal:  Eur J Neurol       Date:  2004-04       Impact factor: 6.089

8.  MRI assessment of basal ganglia iron deposition in Parkinson's disease.

Authors:  Lauren I Wallis; Martyn N J Paley; Jacqueline M Graham; Richard A Grünewald; Emma L Wignall; Harriet M Joy; Paul D Griffiths
Journal:  J Magn Reson Imaging       Date:  2008-11       Impact factor: 4.813

9.  Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fischer 344 rats.

Authors:  M A Hebert; G A Gerhardt
Journal:  Brain Res       Date:  1998-06-22       Impact factor: 3.252

10.  Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function.

Authors:  Penny A Macdonald; Oury Monchi
Journal:  Parkinsons Dis       Date:  2011-03-06
View more
  40 in total

Review 1.  Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.

Authors:  Laura A Berner; Tiffany A Brown; Jason M Lavender; Emily Lopez; Christina E Wierenga; Walter H Kaye
Journal:  Mol Cell Endocrinol       Date:  2018-11-02       Impact factor: 4.102

2.  Dietary fat intake, pesticide use, and Parkinson's disease.

Authors:  Freya Kamel; Samuel M Goldman; David M Umbach; Honglei Chen; Gina Richardson; Marie Richards Barber; Cheryl Meng; Connie Marras; Monica Korell; Meike Kasten; Jane A Hoppin; Kathleen Comyns; Anabel Chade; Aaron Blair; Grace S Bhudhikanok; G Webster Ross; J William Langston; Dale P Sandler; Caroline M Tanner
Journal:  Parkinsonism Relat Disord       Date:  2013-10-01       Impact factor: 4.891

Review 3.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

4.  The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions.

Authors:  Ashraf Virmani; Luigi Pinto; Otto Bauermann; Saf Zerelli; Andreas Diedenhofen; Zbigniew K Binienda; Syed F Ali; Feike R van der Leij
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

5.  GLP-1 receptor agonists for Parkinson's disease.

Authors:  Caroline A Mulvaney; Gonçalo S Duarte; Joel Handley; David Jw Evans; Suresh Menon; Richard Wyse; Hedley Ca Emsley
Journal:  Cochrane Database Syst Rev       Date:  2020-07-23

Review 6.  Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide.

Authors:  Emanuel Monteiro Candeias; Inês Carolina Sebastião; Susana Maria Cardoso; Sónia Catarina Correia; Cristina Isabel Carvalho; Ana Isabel Plácido; Maria Sancha Santos; Catarina Resende Oliveira; Paula Isabel Moreira; Ana Isabel Duarte
Journal:  World J Diabetes       Date:  2015-06-25

7.  High-Fat-Diet-Induced Deficits in Dopamine Terminal Function Are Reversed by Restoring Insulin Signaling.

Authors:  Steve C Fordahl; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2017-01-03       Impact factor: 4.418

8.  The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.

Authors:  Erin M Miller; Francois Pomerleau; Peter Huettl; Vivienne A Russell; Greg A Gerhardt; Paul E A Glaser
Journal:  Neuropharmacology       Date:  2012-09-01       Impact factor: 5.250

Review 9.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

10.  A high fat diet alters metabolic and bioenergetic function in the brain: A magnetic resonance spectroscopy study.

Authors:  Kayla Raider; Delin Ma; Janna L Harris; Isabella Fuentes; Robert S Rogers; Joshua L Wheatley; Paige C Geiger; Hung-Wen Yeh; In-Young Choi; William M Brooks; John A Stanford
Journal:  Neurochem Int       Date:  2016-04-26       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.